Literature DB >> 22911547

The EMT signaling pathways in endometrial carcinoma.

Eva Colas1, Nuria Pedrola, Laura Devis, Tugçe Ertekin, Irene Campoy, Elena Martínez, Marta Llauradó, Marina Rigau, Mireia Olivan, Marta Garcia, Silvia Cabrera, Antonio Gil-Moreno, Jordi Xercavins, Josep Castellvi, Angel Garcia, Santiago Ramon y Cajal, Gema Moreno-Bueno, Xavier Dolcet, Francesc Alameda, Jose Palacios, Jaime Prat, Andreas Doll, Xavier Matias-Guiu, Miguel Abal, Jaume Reventos.   

Abstract

Endometrial cancer (EC) is the most common gynecologic malignancy of the female genital tract and the fourth most common neoplasia in women. In EC, myometrial invasion is considered one of the most important prognostic factors. For this process to occur, epithelial tumor cells need to undergo an epithelial to mesenchymal transition (EMT), either transiently or stably, and to differing degrees. This process has been extensively described in other types of cancer but has been poorly studied in EC. In this review, several features of EMT and the main molecular pathways responsible for triggering this process are investigated in relation to EC. The most common hallmarks of EMT have been found in EC, either at the level of E-cadherin loss or at the induction of its repressors, as well as other molecular alterations consistent with the mesenchymal phenotype-like L1CAM and BMI-1 up-regulation. Pathways including progesterone receptor, TGFβ, ETV5 and microRNAs are deeply related to the EMT process in EC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22911547     DOI: 10.1007/s12094-012-0866-3

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  71 in total

1.  Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.

Authors:  C E Ehrlich; P C Young; F B Stehman; G P Sutton; W M Alford
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

Review 2.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

3.  Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

Authors:  Gennadi V Glinsky; Olga Berezovska; Anna B Glinskii
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.

Authors:  N Dandachi; C Hauser-Kronberger; E Moré; B Wiesener; G W Hacker; O Dietze; G Wirl
Journal:  J Pathol       Date:  2001-02       Impact factor: 7.996

5.  Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors.

Authors:  Donghai Dai; Douglas M Wolf; Elizabeth S Litman; Michael J White; Kimberly K Leslie
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

6.  Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.

Authors:  Marta Monge; Eva Colas; Andreas Doll; Antonio Gil-Moreno; Josep Castellvi; Berta Diaz; Marta Gonzalez; Rafael Lopez-Lopez; Jordi Xercavins; Ramon Carreras; Francesc Alameda; Francesc Canals; Franco Gabrielli; Jaume Reventos; Miguel Abal
Journal:  Carcinogenesis       Date:  2009-05-14       Impact factor: 4.944

7.  Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.

Authors:  Yongyi Wang; Payman Hanifi-Moghaddam; Eline E Hanekamp; Helenius J Kloosterboer; Patrick Franken; Jos Veldscholte; Helena C van Doorn; Patricia C Ewing; J Julie Kim; J Anton Grootegoed; Curt W Burger; Riccardo Fodde; Leen J Blok
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

8.  Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.

Authors:  Gema Moreno-Bueno; David Hardisson; David Sarrió; Carolina Sánchez; Raúl Cassia; Jaime Prat; James G Herman; Manel Esteller; Xavier Matías-Guiu; José Palacios
Journal:  J Pathol       Date:  2003-04       Impact factor: 7.996

9.  ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.

Authors:  Marta Monge; Eva Colas; Andreas Doll; Marta Gonzalez; Antonio Gil-Moreno; Jesus Planaguma; Maite Quiles; Maria Antonia Arbos; Angel Garcia; Josep Castellvi; Marta Llaurado; Marina Rigau; Hafid Alazzouzi; Jordi Xercavins; Francesc Alameda; Jaume Reventos; Miguel Abal
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.

Authors:  S Vonlanthen; J Heighway; H J Altermatt; M Gugger; A Kappeler; M M Borner; M van Lohuizen; D C Betticher
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

View more
  40 in total

1.  Notch-1-mediated esophageal carcinoma EC-9706 cell invasion and metastasis by inducing epithelial-mesenchymal transition through Snail.

Authors:  Tao Wang; Xiaoyan Xuan; Linping Pian; Ping Gao; Hong Hu; Yuling Zheng; Wenqiao Zang; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2014-02

2.  L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition.

Authors:  Mac Versluis; A Plat; M de Bruyn; X Matias-Guiu; J Trovic; C Krakstad; H W Nijman; T Bosse; G H de Bock; H Hollema
Journal:  Virchows Arch       Date:  2018-08-23       Impact factor: 4.064

3.  Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.

Authors:  Tatiana Franceschi; Emeline Durieux; Anne Pierre Morel; Pierre de Saint Hilaire; Isabelle Ray-Coquard; Alain Puisieux; Mojgan Devouassoux-Shisheboran
Journal:  Virchows Arch       Date:  2019-02-09       Impact factor: 4.064

Review 4.  A guided tour of selected issues pertaining to metastatic carcinomas involving or originating from the gynecologic tract.

Authors:  Robert A Soslow; Rajmohan Murali
Journal:  Semin Diagn Pathol       Date:  2017-11-20       Impact factor: 3.464

5.  Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.

Authors:  Núria Pedrola; Laura Devis; Marta Llauradó; Irene Campoy; Elena Martinez-Garcia; Marta Garcia; Laura Muinelo-Romay; Lorena Alonso-Alconada; Miguel Abal; Francesc Alameda; Gemma Mancebo; Ramon Carreras; Josep Castellví; Sílvia Cabrera; Antonio Gil-Moreno; Xavier Matias-Guiu; Juan L Iovanna; Eva Colas; Jaume Reventós; Anna Ruiz
Journal:  Clin Exp Metastasis       Date:  2015-04-30       Impact factor: 5.150

6.  A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer.

Authors:  Laura Romero-Pérez; Pablo Garcia-Sanz; Alba Mota; Susanna Leskelä; Marta Hergueta-Redondo; Juan Díaz-Martín; M Angeles López-García; M Angeles Castilla; Angel Martínez-Ramírez; Robert A Soslow; Xavier Matias-Guiu; Gema Moreno-Bueno; Jose Palacios
Journal:  Mod Pathol       Date:  2015-09-18       Impact factor: 7.842

7.  SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis.

Authors:  Guang-Dong Yang; Xiao-Mei Yang; Huan Lu; Yuan Ren; Ming-Ze Ma; Lin-Yan Zhu; Jing-Hao Wang; Wei-Wei Song; Wen-Ming Zhang; Rong Zhang; Zhi-Gang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  L1CAM: amending the "low-risk" category in endometrial carcinoma.

Authors:  Felix Kommoss; Friedrich Kommoss; Friederike Grevenkamp; Anne-Kathrin Bunz; Florin-Andrei Taran; Falko Fend; Sara Y Brucker; Diethelm Wallwiener; Birgitt Schönfisch; Karen Greif; Sigurd Lax; Annette Staebler; Stefan Kommoss
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-30       Impact factor: 4.553

9.  EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition.

Authors:  Ya-Ting Hsu; Pawel Osmulski; Yao Wang; Yi-Wen Huang; Lu Liu; Jianhua Ruan; Victor X Jin; Nameer B Kirma; Maria E Gaczynska; Tim Hui-Ming Huang
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

10.  Endometrial Tumour Microenvironment.

Authors:  Carlos Casas-Arozamena; Miguel Abal
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.